Galactomannan Is a Biomarker of Fosmanogepix (APX001) Efficacy in Treating Experimental Invasive Pulmonary Aspergillosis.
Antimicrob Agents Chemother
; 64(1)2019 12 20.
Article
in En
| MEDLINE
| ID: mdl-31685475
ABSTRACT
Galactomannan (GM) detection in biological samples has been shown to predict therapeutic response by azoles and polyenes. In a murine invasive pulmonary aspergillosis model, fosmanogepix or posaconazole treatment resulted in an â¼6- to 7-log reduction in conidial equivalents (CE)/g lung tissue after 96 h versus placebo. Changes in GM levels in BAL fluid and serum mirrored reductions in lung CE, with significant decreases seen after 96 h or 72 h for fosmanogepix or posaconazole, respectively (P < 0.02).
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biomarkers
/
Invasive Pulmonary Aspergillosis
/
Mannans
/
Antifungal Agents
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Antimicrob Agents Chemother
Year:
2019
Type:
Article
Affiliation country:
United States